New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cabot Corporation
CBT
Shape
US Flag

NYSE

6B

Chemicals - Specialty

Next Earning date - 04 Nov 2024

6B

Chemicals - Specialty

Next Earning date - 04 Nov 2024

109.26USD
Shape-1.13 ( -1.02%)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

-28%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

7%

Quote Panel

Shape
Updated October 27, 2024
1W -3.19 % 1M -2.25 % 3M 11.18 % 1Y 67.22 %

Key Metrics

Shape
  • Market Cap

    5.99B


  • Shares Outstanding

    54.82M


  • Share in Float

    54.02M


  • Dividende

    1.72


  • Earning Date

    04 Nov 2024


  • Price Target

    109.26


  • Average Volume

    366760


  • Beta

    1.181


  • Range

    65.1-117.14


  • Industry

    Chemicals - Specialty


  • Website

    https://www.cabotcorp.com


  • Sector

    Basic Materials


Fundamentals

Shape

15.81x

P/E Ratio

1.51x

P/S Ratio

4.47x

P/B Ratio

0.8

Debt/Equity

12.1%

Net Margin

$8.4

EPS

How CBT compares to sector?

P/E Ratio

Relative Strength

Shape

CBT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4B

Shape314%

2025-Revenue

$7.82

Shape299%

2025-EPS

$662M

Shape217%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Canaccord Genuity

downgrade

Previous: Not converted

2022-11-16

Now: Hold

Deutsche Bank

downgrade

Previous: Buy

2022-11-16

Now: Hold

Goldman Sachs

downgrade

Previous: Not converted

2022-11-16

Now: Neutral

Evercore ISI

initialise

Previous: Not converted

2022-11-16

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+40%

1.55
vs 1.11

Q4.22

arrow
arrow

-24%

0.98
vs 1.29

Q1.23

arrow
arrow

-21%

1.33
vs 1.69

Q2.23

arrow
arrow

-18%

1.42
vs 1.73

Q3.23

arrow
arrow

+6%

1.65
vs 1.55

Q4.23

arrow
arrow

+59%

1.56
vs 0.98

Q1.24

arrow
arrow

+34%

1.78
vs 1.33

Q2.24

arrow
arrow

+35%

1.92
vs 1.42

Q3.24

arrow
arrow

+10%

1.81
vs 1.65

Q4.24

arrow
arrow

+21%

1.88
vs 1.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+23%

1.1B  vs 904M

Q4.22

arrow
arrow

0%

965M  vs 968M

Q1.23

arrow
arrow

-5%

1B  vs 1.1B

Q2.23

arrow
arrow

-16%

968M  vs 1.1B

Q3.23

arrow
arrow

-13%

965M  vs 1.1B

Q4.23

arrow
arrow

-1%

958M  vs 965M

Q1.24

arrow
arrow

-1%

1B  vs 1B

Q2.24

arrow
arrow

+5%

1B  vs 968M

Q3.24

arrow
arrow

+5%

1B  vs 965M

Q4.24

arrow
arrow

+7%

1B  vs 958M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+10%

0.1
vs 0.11

Q4.22

arrow
arrow

+5%

0.05
vs 0.1

Q1.23

arrow
arrow

+7%

0.07
vs 0.05

Q2.23

arrow
arrow

+7%

0.07
vs 0.07

Q3.23

arrow
arrow

+19%

0.19
vs 0.07

Q4.23

arrow
arrow

+4%

0.04
vs 0.19

Q1.24

arrow
arrow

+6%

0.06
vs 0.04

Q2.24

arrow
arrow

+8%

0.08
vs 0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

310

310
vs 291

7%

Q4.22

arrow
arrow

323

323
vs 310

4%

Q1.23

arrow
arrow

311

311
vs 323

-4%

Q2.23

arrow
arrow

289

289
vs 311

-7%

Q3.23

arrow
arrow

299

299
vs 289

3%

Q4.23

arrow
arrow

338

338
vs 299

13%

Q1.24

arrow
arrow

365

365
vs 338

8%

Q2.24

arrow
arrow

390

390
vs 365

7%

Earnings Growth

Latest News